Fig. 3From: Quantitative benefit-risk assessment of methylprednisolone in multiple sclerosis relapsesDecision tree model used for the benefit-risk assessment of methylprednisolone in MS relapses. Any sub-tree denoted with [+] is identical to the sub-tree immediately above itBack to article page